This company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsESGEN Acquisition (ESAC) 주식 개요ESGEN Acquisition Corporation does not have significant operations. 자세히 보기ESAC 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적1/6재무 건전성1/6배당0/6강점공정 가치 추정치보다 낮은 97.1% 에서 거래위험 분석수익이 USD$1m 미만입니다($0)마이너스 주주 지분지난 3개월 동안 주가 변동성이 US 시장과 비교했을 때 매우 높았습니다.의미 있는 시가총액이 없습니다($64M)+ 위험 1건 추가모든 위험 점검 보기ESAC Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$6.97해당 없음내재 할인율Est. Revenue$PastFuture026m2016201920222025202620282031Revenue US$1.0Earnings US$0AdvancedSet Fair ValueView all narrativesESGEN Acquisition Corporation 경쟁사Chenghe AcquisitionSymbol: NasdaqGM:CHEAMarket cap: US$63.1mA SPAC II AcquisitionSymbol: OTCPK:ASCB.FMarket cap: US$68.2mClean Energy Special SituationsSymbol: OTCPK:SWSSMarket cap: US$51.7mJupiter AcquisitionSymbol: NasdaqCM:JAQCMarket cap: US$62.2m가격 이력 및 성과ESGEN Acquisition 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가US$6.9752주 최고가US$12.3452주 최저가US$5.51베타0.0131개월 변동-38.75%3개월 변동-38.10%1년 변동-33.37%3년 변동n/a5년 변동n/aIPO 이후 변동n/a최근 뉴스 및 업데이트공시 • Mar 14+ 1 more updateESGEN Acquisition Corporation(NasdaqGM:ESAC) dropped from NASDAQ Composite IndexESGEN Acquisition Corporation has been removed from NASDAQ Composite Index.Board Change • Dec 31Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.New Risk • Nov 23New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$93.7m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$7.7m). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (US$93.7m market cap).공시 • Oct 18ESGEN Acquisition Corporation Receives a Written Notice from the Listing Qualifications Department of the Nasdaq Stock MarketOn October 16, 2023, ESGEN Acquisition Corporation received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that, since the Company’s Form 10-Q for the period ended June 30, 2023 reported total holders below the round lot holder requirement under Nasdaq Listing Rule 5450(a)(2), the Company no longer complies with Nasdaq’s Listing Rules. The Notice does not impact the listing of the Company’s Class A ordinary shares, par value $0.0001 per share, on the Nasdaq Global Market at this time. The Notice provided that the Company has a period of 45 days to submit a plan to regain compliance and then, if the plan is accepted, an additional up to 180 calendar days from the date of the Notice, or until April 13, 2024, to regain compliance with the Round Lot Requirement. During this period, Class A ordinary shares will continue to trade on the Nasdaq Global Market. If the plan is not accepted, under Nasdaq Listing Rule 5815(a), the Company may appeal the decision to a Hearings Panel. If the Company does not regain compliance with the Round Lot Requirement by the Compliance Date, the Staff may provide a written notification to the Company that Class A ordinary shares will be subject to delisting. The Company intends to monitor its Round Lot Requirement between now and the Compliance Date, and may, if appropriate, evaluate available options to resolve the deficiency under the Round Lot Requirement and regain compliance with the Round Lot Requirement. The Company may also try to transfer from the Nasdaq Global Market to the Nasdaq Capital Market, which would require the Company to meet the continued listing requirements of the Nasdaq Capital Market under Nasdaq Listing Rule 5550 at the time of the application to transfer. However, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing criteria or meet the continued listing requirements of the Nasdaq Capital Market.공시 • May 12ESGEN Acquisition Receives Written Notice from Nasdaq Regarding Not in Compliance with Nasdaq Listing Rule 5450(b)(2)(A) and 5450(b)(3)(A)On May 10, 2023, ESGEN Acquisition Corporation received a written notice (the ‘Notice’) from the Listing Qualifications Department (the ‘Staff’) of The Nasdaq Stock Market LLC (‘Nasdaq’) notifying the Company that, for the last 30 consecutive business days, the Company’s Market Value of Listed Securities (‘MVLS’) was below the minimum of $50 million required for continued listing on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the ‘Market Value Standard’). The Staff also noted that the Company does not meet the requirements under Nasdaq Listing Rules 5450(b)(3)(A) (the ‘Total Assets/Total Revenue Standard’). The Notice does not impact the listing of the Company’s Class A ordinary shares, par value $0.0001 per share (‘Class A ordinary shares’), on the Nasdaq Global Market at this time. The Notice provided that, in accordance with Nasdaq Listing Rule 5810(c)(3)(C) (the ‘Compliance Period Rule’), the Company has a period of 180 calendar days from the date of the Notice, or until November 6, 2023 (the ‘Compliance Date’), to regain compliance with the Market Value Standard. During this period, Class A ordinary shares will continue to trade on the Nasdaq Global Market. If at any time before the Compliance Date the Company’s MVLS closes at or above $50 million for a minimum of 10 consecutive business days as required under the Compliance Period Rule, the Staff will provide written notification to the Company that it has regained compliance with the Market Value Standard and will close the matter. If the Company does not regain compliance with the Market Value Standard by the Compliance Date, the Staff will provide a written notification to the Company that Class A ordinary shares will be subject to delisting. At that time, the Company may appeal the Staff’s delisting determination to a Hearings Panel (the ‘Panel’). However, there can be no assurance that, if the Company receives a delisting notice and appeals the delisting determination by the Staff to the Panel, such appeal would be successful. The Company intends to monitor its MVLS between now and the Compliance Date, and may, if appropriate, evaluate available options to resolve the deficiency under the Market Value Standard and regain compliance with the Market Value Standard. The Company may also try to comply with another Nasdaq Global Market listing criteria, such as the Total Assets/Total Revenue Standard, or may try to transfer from the Nasdaq Global Market to the Nasdaq Capital Market, which would require the Company to meet the continued listing requirements of the Nasdaq Capital Market under Nasdaq Listing Rule 5550 at the time of the application to transfer. However, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing criteria or meet the continued listing requirements of the Nasdaq Capital Market.공시 • Apr 03ESGEN Acquisition Corporation announced delayed annual 10-K filingOn 04/01/2022, ESGEN Acquisition Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.더 많은 업데이트 보기Recent updates공시 • Mar 14+ 1 more updateESGEN Acquisition Corporation(NasdaqGM:ESAC) dropped from NASDAQ Composite IndexESGEN Acquisition Corporation has been removed from NASDAQ Composite Index.Board Change • Dec 31Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.New Risk • Nov 23New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$93.7m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$7.7m). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (US$93.7m market cap).공시 • Oct 18ESGEN Acquisition Corporation Receives a Written Notice from the Listing Qualifications Department of the Nasdaq Stock MarketOn October 16, 2023, ESGEN Acquisition Corporation received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that, since the Company’s Form 10-Q for the period ended June 30, 2023 reported total holders below the round lot holder requirement under Nasdaq Listing Rule 5450(a)(2), the Company no longer complies with Nasdaq’s Listing Rules. The Notice does not impact the listing of the Company’s Class A ordinary shares, par value $0.0001 per share, on the Nasdaq Global Market at this time. The Notice provided that the Company has a period of 45 days to submit a plan to regain compliance and then, if the plan is accepted, an additional up to 180 calendar days from the date of the Notice, or until April 13, 2024, to regain compliance with the Round Lot Requirement. During this period, Class A ordinary shares will continue to trade on the Nasdaq Global Market. If the plan is not accepted, under Nasdaq Listing Rule 5815(a), the Company may appeal the decision to a Hearings Panel. If the Company does not regain compliance with the Round Lot Requirement by the Compliance Date, the Staff may provide a written notification to the Company that Class A ordinary shares will be subject to delisting. The Company intends to monitor its Round Lot Requirement between now and the Compliance Date, and may, if appropriate, evaluate available options to resolve the deficiency under the Round Lot Requirement and regain compliance with the Round Lot Requirement. The Company may also try to transfer from the Nasdaq Global Market to the Nasdaq Capital Market, which would require the Company to meet the continued listing requirements of the Nasdaq Capital Market under Nasdaq Listing Rule 5550 at the time of the application to transfer. However, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing criteria or meet the continued listing requirements of the Nasdaq Capital Market.공시 • May 12ESGEN Acquisition Receives Written Notice from Nasdaq Regarding Not in Compliance with Nasdaq Listing Rule 5450(b)(2)(A) and 5450(b)(3)(A)On May 10, 2023, ESGEN Acquisition Corporation received a written notice (the ‘Notice’) from the Listing Qualifications Department (the ‘Staff’) of The Nasdaq Stock Market LLC (‘Nasdaq’) notifying the Company that, for the last 30 consecutive business days, the Company’s Market Value of Listed Securities (‘MVLS’) was below the minimum of $50 million required for continued listing on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the ‘Market Value Standard’). The Staff also noted that the Company does not meet the requirements under Nasdaq Listing Rules 5450(b)(3)(A) (the ‘Total Assets/Total Revenue Standard’). The Notice does not impact the listing of the Company’s Class A ordinary shares, par value $0.0001 per share (‘Class A ordinary shares’), on the Nasdaq Global Market at this time. The Notice provided that, in accordance with Nasdaq Listing Rule 5810(c)(3)(C) (the ‘Compliance Period Rule’), the Company has a period of 180 calendar days from the date of the Notice, or until November 6, 2023 (the ‘Compliance Date’), to regain compliance with the Market Value Standard. During this period, Class A ordinary shares will continue to trade on the Nasdaq Global Market. If at any time before the Compliance Date the Company’s MVLS closes at or above $50 million for a minimum of 10 consecutive business days as required under the Compliance Period Rule, the Staff will provide written notification to the Company that it has regained compliance with the Market Value Standard and will close the matter. If the Company does not regain compliance with the Market Value Standard by the Compliance Date, the Staff will provide a written notification to the Company that Class A ordinary shares will be subject to delisting. At that time, the Company may appeal the Staff’s delisting determination to a Hearings Panel (the ‘Panel’). However, there can be no assurance that, if the Company receives a delisting notice and appeals the delisting determination by the Staff to the Panel, such appeal would be successful. The Company intends to monitor its MVLS between now and the Compliance Date, and may, if appropriate, evaluate available options to resolve the deficiency under the Market Value Standard and regain compliance with the Market Value Standard. The Company may also try to comply with another Nasdaq Global Market listing criteria, such as the Total Assets/Total Revenue Standard, or may try to transfer from the Nasdaq Global Market to the Nasdaq Capital Market, which would require the Company to meet the continued listing requirements of the Nasdaq Capital Market under Nasdaq Listing Rule 5550 at the time of the application to transfer. However, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing criteria or meet the continued listing requirements of the Nasdaq Capital Market.공시 • Apr 03ESGEN Acquisition Corporation announced delayed annual 10-K filingOn 04/01/2022, ESGEN Acquisition Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.주주 수익률ESACUS Capital MarketsUS 시장7D3.3%-0.8%-0.3%1Y-33.4%9.8%26.7%전체 주주 수익률 보기수익률 대 산업: ESAC은 지난 1년 동안 9.8%의 수익을 기록한 US Capital Markets 산업보다 저조한 성과를 냈습니다.수익률 대 시장: ESAC은 지난 1년 동안 26.7%를 기록한 US 시장보다 저조한 성과를 냈습니다.주가 변동성Is ESAC's price volatile compared to industry and market?ESAC volatilityESAC Average Weekly Movement22.4%Capital Markets Industry Average Movement3.6%Market Average Movement7.2%10% most volatile stocks in US Market16.2%10% least volatile stocks in US Market3.2%안정적인 주가: ESAC의 주가는 지난 3개월 동안 US 시장보다 변동성이 컸습니다.시간에 따른 변동성: ESAC의 주간 변동성은 지난 1년간 11%에서 22%로 증가했습니다.회사 소개설립직원 수CEO웹사이트2021n/aAndrejka Bernatovawww.esgen-spac.com더 보기ESGEN Acquisition Corporation 기초 지표 요약ESGEN Acquisition의 순이익과 매출은 시가총액과 어떻게 비교됩니까?ESAC 기초 통계시가총액US$63.98m순이익 (TTM)US$471.55k매출 (TTM)n/a122.8x주가수익비율(P/E)0.0x주가매출비율(P/S)ESAC는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표ESAC 손익계산서 (TTM)매출US$0매출원가US$0총이익US$0기타 비용-US$471.55k순이익US$471.55k최근 보고된 실적Sep 30, 2023다음 실적 발표일해당 없음주당순이익(EPS)0.057총이익률0.00%순이익률0.00%부채/자본 비율-18.2%ESAC의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/03/13 06:09종가2024/03/13 00:00수익2023/09/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스ESGEN Acquisition Corporation는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Mar 14+ 1 more updateESGEN Acquisition Corporation(NasdaqGM:ESAC) dropped from NASDAQ Composite IndexESGEN Acquisition Corporation has been removed from NASDAQ Composite Index.
Board Change • Dec 31Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
New Risk • Nov 23New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$93.7m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$7.7m). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (US$93.7m market cap).
공시 • Oct 18ESGEN Acquisition Corporation Receives a Written Notice from the Listing Qualifications Department of the Nasdaq Stock MarketOn October 16, 2023, ESGEN Acquisition Corporation received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that, since the Company’s Form 10-Q for the period ended June 30, 2023 reported total holders below the round lot holder requirement under Nasdaq Listing Rule 5450(a)(2), the Company no longer complies with Nasdaq’s Listing Rules. The Notice does not impact the listing of the Company’s Class A ordinary shares, par value $0.0001 per share, on the Nasdaq Global Market at this time. The Notice provided that the Company has a period of 45 days to submit a plan to regain compliance and then, if the plan is accepted, an additional up to 180 calendar days from the date of the Notice, or until April 13, 2024, to regain compliance with the Round Lot Requirement. During this period, Class A ordinary shares will continue to trade on the Nasdaq Global Market. If the plan is not accepted, under Nasdaq Listing Rule 5815(a), the Company may appeal the decision to a Hearings Panel. If the Company does not regain compliance with the Round Lot Requirement by the Compliance Date, the Staff may provide a written notification to the Company that Class A ordinary shares will be subject to delisting. The Company intends to monitor its Round Lot Requirement between now and the Compliance Date, and may, if appropriate, evaluate available options to resolve the deficiency under the Round Lot Requirement and regain compliance with the Round Lot Requirement. The Company may also try to transfer from the Nasdaq Global Market to the Nasdaq Capital Market, which would require the Company to meet the continued listing requirements of the Nasdaq Capital Market under Nasdaq Listing Rule 5550 at the time of the application to transfer. However, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing criteria or meet the continued listing requirements of the Nasdaq Capital Market.
공시 • May 12ESGEN Acquisition Receives Written Notice from Nasdaq Regarding Not in Compliance with Nasdaq Listing Rule 5450(b)(2)(A) and 5450(b)(3)(A)On May 10, 2023, ESGEN Acquisition Corporation received a written notice (the ‘Notice’) from the Listing Qualifications Department (the ‘Staff’) of The Nasdaq Stock Market LLC (‘Nasdaq’) notifying the Company that, for the last 30 consecutive business days, the Company’s Market Value of Listed Securities (‘MVLS’) was below the minimum of $50 million required for continued listing on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the ‘Market Value Standard’). The Staff also noted that the Company does not meet the requirements under Nasdaq Listing Rules 5450(b)(3)(A) (the ‘Total Assets/Total Revenue Standard’). The Notice does not impact the listing of the Company’s Class A ordinary shares, par value $0.0001 per share (‘Class A ordinary shares’), on the Nasdaq Global Market at this time. The Notice provided that, in accordance with Nasdaq Listing Rule 5810(c)(3)(C) (the ‘Compliance Period Rule’), the Company has a period of 180 calendar days from the date of the Notice, or until November 6, 2023 (the ‘Compliance Date’), to regain compliance with the Market Value Standard. During this period, Class A ordinary shares will continue to trade on the Nasdaq Global Market. If at any time before the Compliance Date the Company’s MVLS closes at or above $50 million for a minimum of 10 consecutive business days as required under the Compliance Period Rule, the Staff will provide written notification to the Company that it has regained compliance with the Market Value Standard and will close the matter. If the Company does not regain compliance with the Market Value Standard by the Compliance Date, the Staff will provide a written notification to the Company that Class A ordinary shares will be subject to delisting. At that time, the Company may appeal the Staff’s delisting determination to a Hearings Panel (the ‘Panel’). However, there can be no assurance that, if the Company receives a delisting notice and appeals the delisting determination by the Staff to the Panel, such appeal would be successful. The Company intends to monitor its MVLS between now and the Compliance Date, and may, if appropriate, evaluate available options to resolve the deficiency under the Market Value Standard and regain compliance with the Market Value Standard. The Company may also try to comply with another Nasdaq Global Market listing criteria, such as the Total Assets/Total Revenue Standard, or may try to transfer from the Nasdaq Global Market to the Nasdaq Capital Market, which would require the Company to meet the continued listing requirements of the Nasdaq Capital Market under Nasdaq Listing Rule 5550 at the time of the application to transfer. However, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing criteria or meet the continued listing requirements of the Nasdaq Capital Market.
공시 • Apr 03ESGEN Acquisition Corporation announced delayed annual 10-K filingOn 04/01/2022, ESGEN Acquisition Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Mar 14+ 1 more updateESGEN Acquisition Corporation(NasdaqGM:ESAC) dropped from NASDAQ Composite IndexESGEN Acquisition Corporation has been removed from NASDAQ Composite Index.
Board Change • Dec 31Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
New Risk • Nov 23New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$93.7m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$7.7m). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (US$93.7m market cap).
공시 • Oct 18ESGEN Acquisition Corporation Receives a Written Notice from the Listing Qualifications Department of the Nasdaq Stock MarketOn October 16, 2023, ESGEN Acquisition Corporation received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that, since the Company’s Form 10-Q for the period ended June 30, 2023 reported total holders below the round lot holder requirement under Nasdaq Listing Rule 5450(a)(2), the Company no longer complies with Nasdaq’s Listing Rules. The Notice does not impact the listing of the Company’s Class A ordinary shares, par value $0.0001 per share, on the Nasdaq Global Market at this time. The Notice provided that the Company has a period of 45 days to submit a plan to regain compliance and then, if the plan is accepted, an additional up to 180 calendar days from the date of the Notice, or until April 13, 2024, to regain compliance with the Round Lot Requirement. During this period, Class A ordinary shares will continue to trade on the Nasdaq Global Market. If the plan is not accepted, under Nasdaq Listing Rule 5815(a), the Company may appeal the decision to a Hearings Panel. If the Company does not regain compliance with the Round Lot Requirement by the Compliance Date, the Staff may provide a written notification to the Company that Class A ordinary shares will be subject to delisting. The Company intends to monitor its Round Lot Requirement between now and the Compliance Date, and may, if appropriate, evaluate available options to resolve the deficiency under the Round Lot Requirement and regain compliance with the Round Lot Requirement. The Company may also try to transfer from the Nasdaq Global Market to the Nasdaq Capital Market, which would require the Company to meet the continued listing requirements of the Nasdaq Capital Market under Nasdaq Listing Rule 5550 at the time of the application to transfer. However, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing criteria or meet the continued listing requirements of the Nasdaq Capital Market.
공시 • May 12ESGEN Acquisition Receives Written Notice from Nasdaq Regarding Not in Compliance with Nasdaq Listing Rule 5450(b)(2)(A) and 5450(b)(3)(A)On May 10, 2023, ESGEN Acquisition Corporation received a written notice (the ‘Notice’) from the Listing Qualifications Department (the ‘Staff’) of The Nasdaq Stock Market LLC (‘Nasdaq’) notifying the Company that, for the last 30 consecutive business days, the Company’s Market Value of Listed Securities (‘MVLS’) was below the minimum of $50 million required for continued listing on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the ‘Market Value Standard’). The Staff also noted that the Company does not meet the requirements under Nasdaq Listing Rules 5450(b)(3)(A) (the ‘Total Assets/Total Revenue Standard’). The Notice does not impact the listing of the Company’s Class A ordinary shares, par value $0.0001 per share (‘Class A ordinary shares’), on the Nasdaq Global Market at this time. The Notice provided that, in accordance with Nasdaq Listing Rule 5810(c)(3)(C) (the ‘Compliance Period Rule’), the Company has a period of 180 calendar days from the date of the Notice, or until November 6, 2023 (the ‘Compliance Date’), to regain compliance with the Market Value Standard. During this period, Class A ordinary shares will continue to trade on the Nasdaq Global Market. If at any time before the Compliance Date the Company’s MVLS closes at or above $50 million for a minimum of 10 consecutive business days as required under the Compliance Period Rule, the Staff will provide written notification to the Company that it has regained compliance with the Market Value Standard and will close the matter. If the Company does not regain compliance with the Market Value Standard by the Compliance Date, the Staff will provide a written notification to the Company that Class A ordinary shares will be subject to delisting. At that time, the Company may appeal the Staff’s delisting determination to a Hearings Panel (the ‘Panel’). However, there can be no assurance that, if the Company receives a delisting notice and appeals the delisting determination by the Staff to the Panel, such appeal would be successful. The Company intends to monitor its MVLS between now and the Compliance Date, and may, if appropriate, evaluate available options to resolve the deficiency under the Market Value Standard and regain compliance with the Market Value Standard. The Company may also try to comply with another Nasdaq Global Market listing criteria, such as the Total Assets/Total Revenue Standard, or may try to transfer from the Nasdaq Global Market to the Nasdaq Capital Market, which would require the Company to meet the continued listing requirements of the Nasdaq Capital Market under Nasdaq Listing Rule 5550 at the time of the application to transfer. However, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing criteria or meet the continued listing requirements of the Nasdaq Capital Market.
공시 • Apr 03ESGEN Acquisition Corporation announced delayed annual 10-K filingOn 04/01/2022, ESGEN Acquisition Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
